跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEACODYL LINCTUS - HSA Drug Approval Details
Approvals
/
HSA
/
BEACODYL LINCTUS
Approved
THERAPEUTIC
BEACODYL LINCTUS
BEACONS PHARMACEUTICALS PTE LTD
🇸🇬 Health Sciences Authority
Approval Date
Mar 25, 1994
Approval ID
dfff6048f81fbde1
Company
BEACONS PHARMACEUTICALS PTE LTD
Type
Therapeutic
Approval Details
Approval Id
dfff6048f81fbde1
Drug Name
BEACODYL LINCTUS
Product Name
BEACODYL LINCTUS
Approval Number
SIN07763P
Approval Date
1994-03-25
Registrant
BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder
BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
ELIXIR
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
BEACONS PHARMACEUTICALS PTE. LTD.
Company Detail Path
/organization/beacons-pharmaceuticals-pte-ltd
Active Ingredients
PROMETHAZINE HCl
3.6 mg/5 ml
CODEINE PHOSPHATE
9 mg/5 ml
CODEINE PHOSPHATE
9 MG/5 ML
PROMETHAZINE HCL
3.6 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 25, 1994
Approval ID
dfff6048f81fbde1
Type
Therapeutic
Back to HSA Approvals